Transcriptional Regulation of the MDR1 Gene by Histone Acetyltransferase and Deacetylase Is Mediated by NF-Y

Por Jin, Shengkan, Scotto, Kathleen W.
Publicado em 1998

Transcriptional regulation of MDR genes

Por Scotto, Kathleen W., Egan, David A.
Publicado em 1998

Methylxanthines Increase Expression of the Splicing Factor SRSF2 by Regulating Multiple Post-transcriptional Mechanisms

Por Shi, Jia, Pabon, Kirk, Scotto, Kathleen W.
Publicado no J Biol Chem (2015)

Ecteinascidin 743, a transcription-targeted chemotherapeutic that inhibits MDR1 activation

Por Jin, Shengkan, Gorfajn, Barbara, Faircloth, Glynn, Scotto, Kathleen W.
Publicado em 2000

Caffeine Regulates Alternative Splicing in a Subset of Cancer-Associated Genes: a Role for SC35

Por Shi, Jia, Hu, Zhen, Pabon, Kirk, Scotto, Kathleen W.
Publicado em 2008

Xanthines Down-Regulate the Drug Transporter ABCG2 and Reverse Multidrug Resistance

Por Ding, Rui, Shi, Jia, Pabon, Kirk, Scotto, Kathleen W.
Publicado em 2012

A role for ABCG2 beyond drug transport: Regulation of autophagy

Por Ding, Rui, Jin, Shengkan, Pabon, Kirk, Scotto, Kathleen W.
Publicado no Autophagy (2016)

Involvement of CtBP1 in the Transcriptional Activation of the MDR1 Gene in Human Multidrug Resistant Cancer Cells

Por Jin, Wei, Scotto, Kathleen W., Hait, William N., Yang, Jin-Ming
Publicado em 2007

MTHFD2- a new twist?

Por Tedeschi, Philip M., Scotto, Kathleen W., Kerrigan, John, Bertino, Joseph R.
Publicado no Oncotarget (2016)

Histone methyltransferase MLL1 regulates MDR1 transcription and chemoresistance

Por Huo, Hairong, Magro, Pellegrino G., Pietsch, E. Christy, Patel, Brijesh, Scotto, Kathleen W.
Publicado no Cancer Res (2010)

The COVID-19 pandemic and research shutdown: staying safe and productive

Por Omary, M. Bishr, Eswaraka, Jeetendra, Kimball, S. David, Moghe, Prabhas V., Panettieri, Reynold A., Scotto, Kathleen W.
Publicado no J Clin Invest (2020)

Species-Specific Differences in Translational Regulation of Dihydrofolate Reductase

Por Hsieh, Yi-Ching, Skacel, Nancy E., Bansal, Nitu, Scotto, Kathleen W., Banerjee, Debabrata, Bertino, Joseph R., Abali, Emine Ercikan
Publicado em 2009

A novel peptide that inhibits E2F transcription and regresses prostate tumor xenografts

Por Xie, Xiaoqi, Bansal, Nitu, Shaik, Tazeem, Kerrigan, John E., Minko, Tamara, Garbuzenko, Olga, Abali, Emine Ercikan, Johnson-Farley, Nadine, Banerjee, Debabrata, Scotto, Kathleen W., Bertino, Joseph R
Publicado em 2014

Modeling and antitumor studies of a modified L–penetratin peptide targeting E2F in lung cancer and prostate cancer

Por Shaik, Tazeem, Rather, Gulam M., Bansal, Nitu, Minko, Tamara, Garbuzenko, Olga, Szekely, Zoltan, Abali, Emine E., Banerjee, Debabrata, Kerrigan, John E., Scotto, Kathleen W., Bertino, Joseph R.
Publicado no Oncotarget (2018)

A second target of benzamide riboside: Dihydrofolate reductase

Por Roussel, Breton, Johnson-Farley, Nadine, Kerrigan, John E., Scotto, Kathleen W., Banerjee, Debabrata, Felczak, Krzysztof, Pankiewicz, Krzysztof W., Gounder, Murugesan, Lin, HongXia, Abali, Emine Ercikan, Bertino, Joseph R.
Publicado em 2012

Antitumor and modeling studies of a penetratin-peptide that targets E2F-1 in small cell lung cancer

Por Xie, Xiaoqi, Kerrigan, John E, Minko, Tamara, Garbuzenko, Olga, Lee, Kuo-Chieh, Scarborough, Alex, Abali, Emine Ercikan, Budak-Alpdogan, Tulin, Johnson-Farley, Nadine, Banerjee, Debabrata, Scotto, Kathleen W, Bertino, Joseph R
Publicado em 2013